NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

VREX | NASDAQ

$18.47 $0.00 | 0.00%
SIGNAL:Signal available — unlock to view |2026-09-23 |F&G 85 |RSI 79.4

Company Overview:

Market Cap: $784.30M
Trailing PE: 35.2x
FWD PE *: 18.1x
Payout Ratio (TTM): —
52-Week Range: $9.09 - $18.63

* Forward PE is based on street estimates.

9.7 Year VREX Performance Metrics:

Total Return (with DRIP): -34.4% (-4.25% CAGR)
Total Return (no DRIP): -34.4% (-4.25% CAGR)
Share Price: -34.4% (-4.25% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $6,561
Total Return $ (with DRIP): -$3,439
VREX Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
VREX Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

VREX Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

VREX - Revenue
VREX Revenue CAGR:1Y: 3.69%2Y: 1.16%5Y: -1.44%10Y: 2.03%
VREX - Earnings Per Share (EPS)
VREX EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 13.09%10Y: -4.56%
VREX - Net Income
🔓 See the full chart40% off right now · 7-day free trial
VREX Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 12.53%10Y: -3.32%
VREX - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
VREX EBITDA CAGR:1Y: 0.00%2Y: 14.10%5Y: -2.99%10Y: -4.88%
VREX - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
VREX Free Cash Flow CAGR:1Y: 757.14%2Y: -22.35%5Y: -24.21%10Y: -2.27%
VREX - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
VREX Free Cash Flow / Share CAGR:1Y: 744.93%2Y: -23.55%5Y: -25.21%10Y: -3.42%
VREX - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
VREX Operating Income CAGR:1Y: 0.00%2Y: 44.63%5Y: -2.96%10Y: -3.63%
VREX - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
VREX Gross Profit CAGR:1Y: 13.63%2Y: 6.91%5Y: 0.29%10Y: 1.03%
VREX - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
VREX Shares Outstanding CAGR:1Y: 2.65%2Y: 2.18%5Y: -0.42%10Y: 1.31%
VREX - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
VREX Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
VREX - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
VREX Stock-Based Comp CAGR:1Y: 2.70%2Y: 4.20%5Y: 2.86%10Y: 4.28%
VREX - Expenses
🔓 See the full chart40% off right now · 7-day free trial
VREX Expenses CAGR:1Y: 42.86%2Y: 22.47%5Y: 28.19%10Y: 6.71%
VREX - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
VREX - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
VREX - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
VREX - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
VREX - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
VREX - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
VREX - Revenue by Segment
🔓 See the full chart40% off right now · 7-day free trial
VREX Revenue CAGR:1Y: 3.69%2Y: 1.16%5Y: -1.44%10Y: 2.03%
VREX - Revenue by Region
🔓 See the full chart40% off right now · 7-day free trial
VREX Revenue CAGR:1Y: 3.69%2Y: 1.16%5Y: -1.44%10Y: 2.03%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

VREX - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
VREX Actual Revenue CAGR:1Y: 3.69%2Y: 1.16%5Y: -1.44%10Y: 2.03%
VREX - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
VREX Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 13.09%10Y: -4.56%
VREX - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
VREX Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 12.53%10Y: -3.32%
VREX - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
VREX Actual EBITDA CAGR:1Y: 0.00%2Y: 14.10%5Y: -2.99%10Y: -4.88%

Ratios, Profit Margins & Return on Capital:

VREX - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
VREX Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 14.20%10Y: -5.24%
VREX - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
VREX Gross Profit Margin CAGR:1Y: 9.59%2Y: 5.69%5Y: 1.75%10Y: -0.98%
VREX - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
VREX Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: -26.02%10Y: -4.99%
VREX - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
VREX Price To Sales Ratio CAGR:1Y: 17.95%2Y: -5.26%5Y: -15.67%10Y: -10.05%
VREX - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
VREX Return on Capital Employed CAGR:1Y: 0.00%2Y: 52.98%5Y: -1.55%10Y: -8.48%
VREX - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
VREX Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 7.90%10Y: -5.66%

Compare stocks side-by-side

Projected Future Returns & Dividends for VREX

Based on past 9.7-year performance, here are VREX growth metrics:

Share price CAGR of -4.25%
Dividend CAGR of +0%

Using VREX CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

VREX (DRIP)VREX - No DRIP
Current Price$18.47$18.47
Start Shares541.42541.42
Start Value$10,000$10,000
  
After 10 years:
Final Share Count541.42541.42
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$11.96$18.47
Total Dividends$0$0
Final Value$6,476$10,000

Estimated Future Value + Dividends - VREX

NOTE: Above numbers are our estimate based on VREX's Dividend and Price CAGR over past 9.7 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

Company Info

Varex Imaging Corporation (VREX) had its IPO on 2017-01-23, and is traded on NASDAQ stock exchange.

Varex Imaging Corporation (VREX) specializes in the development and production of X-ray imaging components. Its operations are divided into two primary divisions: Medical and Industrial. Within the Medical segment, Varex provides a comprehensive range of X-ray imaging components. These include essential hardware like X-ray tubes, digital detectors, and high-voltage connectors, alongside sophisticated software solutions for image processing, 3D reconstruction, and computer-aided diagnostics. The segment also supplies critical ancillary devices such as collimators, generators, and automatic exposure control mechanisms. These medical products serve a wide spectrum of applications, from general diagnostic imaging like radiography and fluoroscopy, to specialized areas such as mammography, computed tomography (CT), cardiac procedures, dental imaging, and surgical applications. They are also vital for radiation therapy, oncology, and advanced computer-aided detection systems. The Industrial segment focuses on providing X-ray technology for security and industrial inspection. Its offerings include Linatron X-ray accelerators, X-ray tubes, digital detectors, and high-voltage connectors. These components are crucial for diverse applications such as airport security scanning, cargo screening at border crossings, and nondestructive testing across various industries. Varex distributes its products through multiple channels, including direct sales to end-users, partnerships with imaging system Original Equipment Manufacturers (OEMs), independent service providers, and a network of distributors. With a significant global footprint, the company maintains operations across North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Established in 2016, Varex Imaging Corporation is headquartered in Salt Lake City, Utah.

VREX website: https://www.vareximaging.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)
Loading signals…

DCF Model — VREX

Value from:
Pay up to today
—
vs current price $18.47
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →